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Abstract 
Background: Previous evidence regarding the associations between serum calcium concentrations, dietary calcium 
intake, and type 2 diabetes (T2D) is limited. We investigated the longitudinal associations of serum calcium levels and 
dietary calcium intake with T2D development.
Methods: This study used data from the Ansung–Ansan cohort, a community‑based, prospective cohort that was 
followed up for 10 years. Cox regression models adjusted for potential confounders were used to evaluate the asso‑
ciations of serum calcium levels (mean, 9.41 mg/dL) and dietary calcium intake (median, 389.59 mg/day) with T2D 
incidence. Association between dietary calcium intake and serum calcium levels was assessed using linear regression 
models.
Results: Albumin‑adjusted serum calcium levels were not associated with T2D risk (hazard ratio [HR] = 1.07, 95% 
confidence interval [CI] 0.96, 1.19, p‑value = 0.2333). A one‑unit increase in log‑transformed, energy‑adjusted dietary 
calcium intake was associated with a decreased risk of T2D (HR = 0.88, 95% CI 0.77, 1.00, p‑value = 0.0460) and lower 
albumin‑adjusted serum calcium levels (β = − 0.04, 95% CI − 0.07, − 0.02, p‑value = 0.0014). The associations did not 
differ according to sex (all p‑values for interaction > 0.10).
Conclusions: Serum calcium levels were not associated with T2D risk, while higher dietary calcium intake was 
associated with a decreased risk of T2D development. These results have public health implications for predicting and 
preventing T2D development, as well as providing guidelines for diet and calcium supplementation.
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Background
Type 2 diabetes (T2D) is one of the most important 
public health issues worldwide, with the past few dec-
ades witnessing a rapid increase in the global number of 
affected patients [1]. Recently, limited number of stud-
ies have reported that higher serum calcium levels are 
associated with an increased risk of T2D development 
[2–5]. However, the association between serum calcium 
levels and T2D development was not observed in another 
epidemiological study [6]. In addition, the positive asso-
ciations between serum calcium levels and T2D were 
unexpected, considering that higher calcium intake has 
been associated with lower T2D risk [7, 8].
Because the previous evidences on the associations 
between serum calcium concentrations, dietary cal-
cium intake, and T2D development are inconsistent 
and limited, further investigation into these complex 
relationships are needed for predicting and preventing 
T2D development and providing scientific guidelines 
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Therefore, in the present study, we evaluated the longi-
tudinal associations of serum calcium levels and dietary 
calcium intake with incidence of T2D in a community-
based, prospective cohort, followed up for 10 years. We 
also assessed the association between dietary calcium 
intake and serum calcium levels at the baseline survey.
Methods
Study design and population
The present study was conducted using data from 
the Ansung–Ansan cohort, an ongoing community-
based, prospective cohort. Detailed information on the 
Ansung–Ansan cohort are presented elsewhere [9]. In 
brief, 10,038 participants aged 40–69 years who resided 
in the Ansung or Ansan regions of the Republic of Korea 
were recruited between 2001 and 2003 using a two-stage 
cluster sampling method. Follow-up surveys were con-
ducted biennially. During each survey, participants took 
part in interviews using structured questionnaires, health 
examinations, and laboratory tests.
Among the 10,038 participants in the Ansung–Ansan 
cohort, 676 were excluded from analysis because they 
reported at enrollment that they had been previously 
diagnosed with T2D. In addition, 560 participants were 
excluded from analysis because they had prevalent 
T2D during the baseline survey, as determined by pre-
defined criteria, based on fasting glucose concentra-
tion (≥ 126  mg/dL), post-load glucose concentration 
(≥ 200  mg/dL), and antidiabetic medication use. Two 
participants who lacked information on serum calcium 
levels were also excluded, resulting in the inclusion of 
8800 participants in the final analysis. In summary, the 
exclusion criteria of the present study was presence of 
T2D and absence of serum calcium levels, and therefore, 
individuals with hypertension, dyslipidemia, or chronic 
kidney disease were included in the analysis. The pre-
sent study used a sequential modeling approach and 
conducted several analyses with different covariate sets. 
Therefore, the number of samples used for each analy-
sis was different between models, and this information, 
along with the results, is presented.
The Ansung–Ansan study protocol was reviewed and 
approved by the Institutional Review Board of the Korea 
Centers for Disease Control and Prevention, and all study 
participants submitted written informed consent. The 
present study was approved by the Ethical Review Board 
of Seoul National University Hospital (C-1306-046-495).
Serum and dietary calcium assessment
Serum calcium and albumin were enzymatically 
measured at the baseline survey using a 747 Chemis-
try Analyzer (Hitachi, Tokyo, Japan). Since total cal-
cium levels may vary with serum albumin levels due to 
calcium-albumin binding, serum calcium concentrations 
were adjusted for albumin concentrations [2] using the 
following equation:
The adjusted level was then used as an explanatory var-
iable in the analysis.
Dietary data were collected during the baseline survey 
by trained interviewers using a validated semi-quantita-
tive food frequency questionnaire [10]. The study par-
ticipants reported the average consumption frequency 
and portion size of 103 food items during the previous 
years, and daily nutrient and total energy intake were 
calculated using the dietary habit information, as well 
as the nutrient and energy content for each food item. 
To control for potential confounding by energy intake, 
daily calcium intake was adjusted by total energy intake 
using the residual method [11]. Since the distribution of 
energy-adjusted calcium intake was highly skewed, log-
transformed values were used in the analysis. The same 
analyses were also conducted using log-transformed cal-
cium intake not adjusted for total energy intake, to assess 
the robustness of the results.
Definition of T2D
During each survey, a 75-g oral glucose tolerance test 
was performed for participants who were not known to 
have T2D and had not started diabetes treatment since 
the last survey. T2D was defined as any of the follow-
ing conditions: fasting glucose concentration ≥ 126  mg/
dL, post-load 2-h glucose concentration ≥ 200 mg/dL, or 
antidiabetic medication use. In the present analysis, data 
for T2D detection was available for every survey from the 
baseline survey conducted in 2001–2003, up to the fifth 
follow-up survey conducted in 2011–2012.
Statistical analysis
The associations of albumin-adjusted serum calcium lev-
els and energy-adjusted dietary calcium intake with T2D 
development were assessed using the Cox proportional 
hazards models with age as the time scale. The poten-
tial nonlinearity of the association was assessed through 
nonparametric analysis that applied spline smoothing 
methods [12].
We constructed analytical models by including covari-
ates assessed at the baseline survey sequentially, to con-
firm robustness of the results. We selected the covariates 
based on previous literature and assumed biological 
pathways [2–5, 13]: (1) adjusted for age and sex; (2) fur-
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monthly family income (< $869, $869–1738, $1738–
3475, or ≥ $3475), tobacco smoking (non-smoker, ex-
smoker, current smoker), alcohol intake (non-drinker, 
ex-drinker, or current drinker), physical activity (none, 
< 3, or ≥ 3 episodes/week, with each episode defined as 
exercising for more than 30 min), and body mass index 
(< 18.5, 18.5–25, 25–30, or ≥ 30; weight divided by height 
squared, kg/m2); (3) further adjusted for systolic blood 
pressure (mmHg), diastolic blood pressure (mmHg), and 
serum creatinine level (mg/dL). Finally, we constructed 
the analytical model mutually adjusted for serum calcium 
levels and dietary calcium intake, by including terms for 
serum calcium levels, dietary calcium intake, and above-
mentioned covariates. To approximate the normal distri-
bution, log-transformed values of dietary calcium intake 
and serum creatinine level were used in the analysis.
We assessed the cross-sectional association between 
dietary calcium intake and serum calcium levels at the 
baseline survey by linear regression models adjusted for 
the same covariate sets.
Potential heterogeneity of the associations of serum 
calcium levels and dietary calcium intake with T2D 
according to sex was explored because many of the pre-
vious studies only examined the association of calcium 
intake with T2D in women [7, 8, 14]. Interactions with 
sex were evaluated with the likelihood ratio test, by 
testing the product terms between sex and serum cal-
cium levels or dietary calcium intake added to the main 
models.
We evaluated the robustness of the results by excluding 
those who had used diuretics or those who were using 
diuretics, because diuretics could also affect serum cal-
cium levels.
All analyses were conducted using SAS version 9.4 
(SAS Institute Inc., Cary, NC) and R version 3.2.5 (The 
Comprehensive R Archive Network, Vienna, Austria: 
http://cran.r-proje ct.org).
Results
Baseline participant characteristics and associated serum 
calcium levels are presented in Table 1. The mean age at 
enrollment was 51.8 years, and there was a slightly higher 
proportion of women (53%) than men (47%). Majority of 
the participants were non-smokers (59%), current drink-
ers (47%), and did not exercise regularly (75%). The mean 
body mass index was 24.5  kg/m2. The mean (standard 
deviation) albumin-adjusted serum calcium level was 
9.41 (0.52) mg/dL (first quartile, 9.12  mg/dL; median, 
9.48  mg/dL; third quartile, 9.76  mg/dL). The median 
(interquartile range) dietary calcium intake was 389.59 
(283.71) mg/day (first quartile, 268.94  mg/day; third 
quartile, 552.65 mg/day).
The associations of serum calcium levels and dietary 
calcium intake with T2D were found to be robust in 
penalized regression spline models (Fig. 1). In the fully-
adjusted Cox proportional hazard models, we did not 
find the evidence for the association between serum cal-
cium levels and risk of T2D (Table  2). However, a one-
unit increase in log-transformed energy-adjusted dietary 
calcium intake was associated with a lower risk of T2D 
(Table  3). The associations between dietary calcium 
intake and T2D did not change appreciably between 
models not adjusted for serum calcium levels (hazard 
ratio [HR] = 0.87, 95% confidence interval [CI] 0.77, 0.99) 
and models adjusted for serum calcium levels (HR = 0.88, 
95% CI 0.77, 1.00). These results were robust in analyses 
using dietary calcium not adjusted for total energy intake 
(data not shown).
When we assessed the association between dietary 
calcium intake and serum calcium levels at the baseline 
survey by linear regression model, dietary calcium intake 
was inversely associated with serum calcium levels after 
adjusting for potential confounders (β = − 0.04, 95% CI 
− 0.07, − 0.02).
The associations of serum calcium levels and dietary 
calcium intake with T2D did not differ according to sex 
(p > 0.10 for all interactions).
After excluding those who had used diuretics (14 par-
ticipants, 0.16%) or those who were using diuretics at the 
baseline survey (8 participants, 0.09%), the results were 
almost similar.
Discussion
In the present study with a community-based cohort 
followed-up for 10 years, the association between serum 
calcium levels and a risk of incident T2D was not evident, 
while higher dietary calcium intake was associated with a 
decreased risk of incident T2D.
Previous studies on the association between serum 
calcium levels and T2D have demonstrated inconsistent 
results. In a population-based prospective cohort study 
conducted in Norway, higher serum calcium concentra-
tions were associated with an increased risk of incident 
T2D [3]. In a multicenter epidemiological study in the 
United States, in which participants were surveyed twice 
at an average of 5.2-year intervals, serum calcium levels 
from the first survey predicted an increased detection 
of T2D in the second survey [4]. In another prospec-
tive cohort study conducted among individuals with 
high cardiovascular risk in Spain, higher serum calcium 
levels were associated with T2D risk [2]. In a retrospec-
tive cohort study in China, elevated serum calcium lev-
els were also associated with T2D risk [5]. However, in 
a prospective cohort study in Finland with a median fol-
low-up of 23.1  years, levels of ionized calcium, a direct 
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measurement of active serum calcium, were not associ-
ated with a T2D risk. The reason for the inconsistency in 
the results is not clear. However, differences in popula-
tion characteristics such as race, genetic background, and 
vitamin D, parathyroid, and phosphorus levels might be 
responsible for the inconsistency. In addition, difference 
in measurement errors in exposure and outcome and dif-
ferent covariates adjusted in analytical models might also 
contribute to the inconsistency. Because the number of 
studies exploring this association is limited, further stud-
ies, especially those using direct measure of active cal-
cium, are warranted.
Table 1 Baseline characteristics and albumin-adjusted serum calcium concentrations of the study participants (n = 8800)
SD standard deviation, HOMA-IR homeostatic model assessment-insulin resistance index, HbA1c glycated hemoglobin
a Values are presented as n (%) for categorical variables, mean (standard deviation) for age, systolic blood pressure, diastolic blood pressure, estimated glomerular 
filtration rate, fasting glucose level, post-load 2-h glucose level, and Hb1Ac or geometric mean (geometric standard deviation) for the other continuous variables
b Albumin-adjusted serum calcium concentrations (mg/dL)
c p-values are estimated by one-way analysis of variance for categorical variables and bivariate linear regression analysis for continuous variables
Characteristics Valuesa Calciumb, mean (SD) p-valuec
Sex < 0.0001
 Men 4105 (47) 9.38 (0.56)
 Women 4695 (53) 9.44 (0.48)
Area < 0.0001
 Ansung 4358 (50) 9.44 (0.49)
 Ansan 4442 (50) 9.38 (0.54)
Monthly family income < 0.0001
 < $869 3000 (35) 9.48 (0.49)
 $869–$1738 2561 (30) 9.41 (0.50)
 $1738–$3475 2443 (28) 9.35 (0.54)
 ≥ $3475 634 (7) 9.24 (0.56)
Tobacco smoking < 0.0001
 Non‑smoker 5160 (59) 9.42 (0.49)
 Ex‑smoker 1305 (15) 9.34 (0.56)
 Current smoker 2216 (26) 9.40 (0.55)
Alcohol intake < 0.0001
 Non‑drinker 4036 (46) 9.43 (0.49)
 Ex‑drinker 546 (6) 9.42 (0.53)
 Current drinker 4137 (47) 9.38 (0.54)
Physical activity 0.0014
 None 6629 (75) 9.42 (0.52)
 < 3 episodes/week 428 (5) 9.35 (0.53)
 ≥ 3 episodes/week 1743 (20) 9.38 (0.51)
Body mass index (kg/m2) 0.0005
 < 18.5 167 (2) 9.42 (0.51)
 18.5–25 4997 (57) 9.39 (0.52)
 25–30 3225 (37) 9.43 (0.52)
 ≥ 30 407 (5) 9.48 (0.49)
Age (years) 51.8 (8.8) < 0.0001
Systolic blood pressure (mmHg) 120.1 (18.8) < 0.0001
Diastolic blood pressure (mmHg) 79.6 (12.1) 0.0073
Estimated glomerular filtration rate (mL/min/1.73 m2) 73.7 (13.9) < 0.0001
HOMA‑IR 1.3 (1.9) 0.0049
Insulinogenic index 0.4 (3.9) 0.0247
Fasting glucose (mg/dL) 83.0 (8.8) < 0.0001
Post‑load 2‑h glucose (mg/dL) 115.3 (30.9) 0.4335
HbA1c (%) 5.6 (0.4) < 0.0001
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Four large cohort studies have investigated the 
association between calcium intake and T2D in the 
United States (n = 83,779 [7], (n = 41,186) [14]), China 
(n = 64,191) [8], and Japan (n = 59,796) [15]. These stud-
ies reported inverse associations between dietary or total 
calcium intake and T2D risk among women in the United 
States, women in China, or individuals with higher vita-
min D intake in Japan. Another cohort study conducted 
in rural areas in Korea (n = 8313) also reported an inverse 
association between total and vegetable calcium intake, 
and T2D risk among women [16]. However, a relatively 
small study (n = 5200) in Australia found no associa-
tion between dietary calcium and T2D [17]. Addition-
ally, studies provided mixed results when investigating 
the association between dairy products (a key dietary 
calcium source) and T2D. One confounder could be the 
high fat content in some dairy products, which may miti-
gate the protective effects of calcium [8, 18]. Calcium 
Fig. 1 Penalized regression spline model for the associations of albumin‑adjusted serum calcium levels and energy‑adjusted dietary calcium 
intake with incidence of type 2 diabetes. a Association between albumin‑adjusted serum calcium intake and risk of type 2 diabetes. b Association 
between energy‑adjusted dietary calcium intake and risk of type 2 diabetes. Solid line, spline curve; shaded area, 95% confidence interval. The 
models were adjusted for age, sex, residential area, monthly family income, tobacco smoking, alcohol intake, physical activity, body mass index, 
systolic blood pressure, diastolic blood pressure, and serum creatinine level
Table 2 Association between albumin-adjusted serum 
calcium levels and type 2 diabetes in the Ansung–Ansan 
cohort of the Korean Genome and Epidemiology Study 
(KoGES)
a Number of study participants included in each analysis
b Adjusted for age and sex
c Adjusted as in Model 1, and further adjusted for residential area, monthly 
family income, tobacco smoking, alcohol intake, physical activity, and body mass 
index
d Adjusted as in Model 2, and further adjusted for systolic blood pressure, 
diastolic blood pressure, and serum creatinine level
e Adjusted as in Model 3, and further adjusted for dietary calcium intake




Model  1b 8800 1.10 0.99, 1.22 0.0919
Model  2c 8534 1.10 0.98, 1.22 0.0947
Model  3d 8525 1.07 0.96, 1.19 0.2125
Model  4e 8433 1.07 0.96, 1.19 0.2333
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intake may also depend on non-dairy foods, includ-
ing tofu, fish, rice, vegetables, and legumes, so the main 
source of dietary calcium may differ across populations 
and cultures [8]. Thus, geographically diverse studies may 
help to evaluate the association between calcium intake 
and T2D by reducing the effects of this potential con-
founder. However, possibility that the observed inverse 
association between dietary calcium intake and T2D risk 
might be attributable to dietary source of calcium still 
remains.
In the present study, serum calcium levels were not 
associated with T2D risk, while dietary calcium intake 
was inversely associated with T2D risk. This might be 
because serum calcium levels could reflect not only exog-
enous calcium intake but also the ability to maintain 
homeostasis.
Dietary calcium intake was inversely associated with 
serum calcium levels. Although vitamin D insufficiency is 
highly prevalent in the Republic of Korea [19] and lower 
calcium intake was reported to be associated with an 
increased parathyroid hormone levels in individuals with 
low serum vitamin D levels [20], to our knowledge, there 
has been few study directly investigating these inverse 
association and underlying mechanisms. Further studies 
using the information on vitamin D or parathyroid hor-
mone are warranted.
Calcium reportedly functions in intracellular processes 
mediated by insulin in skeletal muscle and adipose tissue, 
and potentially affects insulin sensitivity in these insulin-
responsive tissues [21, 22]. Calcium is also essential for 
insulin secretion from pancreatic β-cells in response to 
elevated blood glucose levels, acting via voltage-gated 
calcium channels or large transient receptor poten-
tial channels [23]. Increased calcium intake may also 
decrease the risk of osteoporosis and reduce the release 
of environmental pollutants such as lead, which are 
sequestered in bone and can increase insulin resistance 
and T2D risk [24]. In addition, an inverse association 
between dietary calcium intake and a risk of T2D may be 
indirectly attributable to changes in gastrointestinal hor-
mones or intestinal microbiota and integrity [25].
There are several limitations of the present study. First, 
although ionized calcium is physiologically active and a 
measurable biomarker of calcium homeostasis, the per-
tinent data were not available. Instead, the present study 
used albumin-adjusted serum calcium levels, which is 
highly correlated with ionized calcium with large sam-
ple sizes [26], to consider variation in total calcium levels 
according to serum albumin [2, 4, 5]. Second, although 
vitamin D or parathyroid hormone may affect the asso-
ciation between serum calcium levels and T2D, we had 
no information available regarding these biomarkers. 
This limited our ability to comprehensively evaluate the 
associations between calcium, vitamin D, parathyroid 
hormone, and T2D. Third, calcium supplement informa-
tion was lacking, which could result in misclassification 
of total exogenous calcium intake.
However, the present study also has considerable 
strengths. The study used data from a well-designed, 
community-based prospective cohort that was followed 
up for 10  years. The data included various clinical, die-
tary, and epidemiological traits; they provided a unique 
opportunity to investigate the complex association 
between serum calcium levels, dietary calcium intake, 
and incident T2D.
Conclusions
Serum calcium levels were not associated with a T2D 
risk, but higher dietary calcium intake was associated 
with a decreased T2D risk. The present results have 
potential public health implications for predicting and 
preventing T2D development, as well as providing guide-
lines for diet and calcium supplementation. Because pre-
vious evidence regarding the association between serum 
calcium levels, dietary calcium intake, and T2D are insuf-
ficient, further studies conducted among different popu-
lations are warranted to confirm the present results.
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